Chinese Market for Blood-Pressure Monitors on the Rise
Date: 09 February 2007

Wellingborough, UK – 9^th February 2007 – A new report from InMedica forecasts that shipments of home-use digital blood-pressure monitors to the Chinese market will grow at a CAGR of over 33%, driven by increased awareness and affordability.

Hypertension is one of the biggest risk factors for cardiovascular disease in China, with over a third of all Chinese adults estimated to suffer from high blood-pressure. A recent survey by the World Health Organisation (WHO) shows that the mortality rate of cardiovascular diseases for people in China aged 35 to 64 is an alarming 22%, compared to 12% in the USA. By encouraging better health education, raising the profile of healthcare in the home and recommending the use of devices such as home-use blood-pressure-monitors, the Chinese Government is making steps towards a health system reform.

Many large manufacturers of home-use blood-pressure monitors have recently moved production to China to reduce manufacturing costs. Many local start-ups have also emerged and many are finding success providing OEM manufacturing services for retailers around the world. The increasingly competitive market has also driven prices down significantly, allowing higher penetration into general consumer markets. Home-use digital blood-pressure monitors are now widely available, commonly found on the shelves of a variety of chain retail stores.

Steven Burton, analyst at InMedica and author of the report, “The World Market for Home-Use Digital Blood-Pressure Monitors 2006,” commented, “A particularly high proportion of the Chinese population suffer from hypertension, which is a problem that needs to be addressed. Home-use digital blood pressure monitors are a useful tool for patients to better understand and manage their condition once they have been diagnosed, reducing the need for routine visits to a doctor. For a burdened health system this is a particular bonus. Together with a raise in health awareness of the general public and increasing affordability, home-use digital blood-pressure monitors are expected to prove a popular device.”

Contacting Us

Jonathan Cassell
Senior Manager, Editorial
jonathan.cassell@ihs.com
Direct: + 1 408 654 1714
Mobile: + 408 921 3754

Or

IHS Media Relations
press@ihs.com
Direct: +1 303 305 8021

About IHS Inc. (www.ihs.com)

IHS (NYSE: IHS) is the leading source of information, insight and analytics in critical areas that shape today’s business landscape. Businesses and governments in more than 165 countries around the globe rely on the comprehensive content, expert independent analysis and flexible delivery methods of IHS to make high-impact decisions and develop strategies with speed and confidence. IHS has been in business since 1959 and became a publicly traded company on the New York Stock Exchange in 2005. Headquartered in Englewood, Colorado, USA, IHS is committed to sustainable, profitable growth and employs more than 6,000 people in 31 countries around the world.

IHS is a registered trademark of IHS Inc. All other company and product names may be trademarks of their respective owners. Copyright © 2013 IHS Inc. All rights reserved.